Publications
215
Citations
2,481
Est. group size
~14
Recurring co-author estimate
Active years
19
Publishing since 2008
Jennifer H. Aldrink is a pediatric surgical oncologist whose work focuses on the surgical treatment and outcomes of childhood cancers, especially kidney tumors like Wilms tumor, as well as neuroblastoma, liver tumors, and other rare pediatric malignancies. Much of her research involves large multi-institutional collaborations, including the Pediatric Surgical Oncology Research Collaborative and the Children's Oncology Group, to study surgical techniques, risk stratification, and long-term outcomes for children with cancer. She also contributes to clinical practice guidelines and consensus statements shaping how pediatric cancer surgery is performed and taught.
Publication output has grown over the last decade, rising from roughly 7-9 papers per year in 2017-2018 to over 20-30 per year in 2023-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Current Challenges in Pediatric Hematology and Oncology: An Integrated Multidisciplinary Perspective
European Journal Of Haematology · 2026
- Indocyanine Green Fluorescence for Intraoperative Tumor Identification During Resection of Pediatric and Adolescent Intra-Abdominal Malignancy: A Prospective Multi-Institutional Observational Study
Journal of the American College of Surgeons · 2026
- Outcomes and Surgical Management of Malignant Rhabdoid Tumor of the Kidney: A Report From the Pediatric Surgical Oncology Research Collaborative
Pediatric Blood & Cancer · 2026
- Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients: A Pediatric Surgical Oncology Research Collaborative prospective observational study
Cancer · 2026
- Clinical and Pathologic features of 535 Patients with Congenital Mesoblastic Nephroma
Annals of Surgery · 2025
- ASO Visual Abstract: Essential Knowledge and Skills for the Practice of Pediatric Surgical Oncology: a Modified Delphi Consensus Study by the APSA Cancer Committee
Annals of Surgical Oncology · 2025
- ASO Author Reflections: Cancer Surgery in Infants and Children: Developing an International Consensus
Annals of Surgical Oncology · 2025
- Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials
Nature Reviews Urology · 2025
- Recent Progress and Current Challenges in the Care of the Child Around the World
Journal of Pediatric Surgery · 2025
- Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection
Pediatric Blood & Cancer · 2025
- Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation
Pediatric Blood & Cancer · 2025
- Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor
Annals of Surgery · 2025
- Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study
Pediatric Blood & Cancer · 2025
- How Pediatric Readiness can Impact Pediatric Trauma From Every Day to Mass Events
Journal of Pediatric Surgery · 2025
- Next-Generation Imaging Techniques for Surgical Guidance in Pediatric Tumors
Annals of Surgical Oncology · 2025
- Journal of Pediatric Surgery×50
- Pediatric Blood & Cancer×19
- Journal of Surgical Research×9
- Seminars in Pediatric Surgery×8
- Annals of Surgical Oncology×8
- Mark Ranalli
Medicine · The Ohio State University
- Brian Weiss
Medicine · Indiana University
- Jennifer Sturgis
Medicine · Purdue University West Lafayette
- Keri A. Streby
Medicine · The Ohio State University
- Nathaniel W. Mabe
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile